 control clinic trial murin monoclon igm antibodi treatment gram-neg sepsi xoma sepsi studi group object efficaci adjunct monoclon antibodi antiendotoxin immunotherapi patient gram-neg sepsi design double-blind placebo-control trial set thirty-thre university-affili center veteran commun municip hospit patient adult sign gram-neg infect system septic respons intervent patient mg/kg murin monoclon antibodi gram-neg endotoxin placebo second infus hour main outcom measur mortal studi period resolut organ failur safeti result eighty-six patient sixteen gram-neg sepsi bacterem nonbacterem surviv differ signific patient patient gram-neg sepsi shock studi entri treatment surviv rel risk resolut individu organ failur frequent patient patient group vs placebo group revers allerg reaction patient receiv toxic conclus treatment antiendotoxin antibodi safe mortal resolut organ failur patient gram-neg sepsi shock